Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Abstract

1. •

   This Clinical Practice Guideline provides key recommendations for managing rare endocrine tumours.

2. •

   Neuroendocrine neoplasms of different origins, parathyroid carcinoma and intrathyroid thymic neoplasms are included.

3. •

   The guideline covers clinical imaging and pathological diagnosis, staging and risk assessment, treatment and follow-up.

4. •

   The authors comprise a multidisciplinary group of experts from different institutions and countries in Europe.

5. •

   Recommendations are based on available scientific data and the authors’ collective expert opinion.

Keywords: ESMO guideline; diagnosis; intrathyroid carcinoma; management; parathyroid carcinoma; rare endocrine neoplasms.